ESAB Shorts Edge Lower, But Analysts Cut Hard Ahead of October Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ESAB enters its October 30 earnings date with short sellers trimming positions even as analysts race to lower their targets, a split that puts the stock's 8.5% short interest figure in an unusual light.
Short interest has been edging down this week, falling roughly 0.1% over the past five days to 5.16 million shares, equivalent to 8.5% of the free float. That is still a meaningful position, up about 1.7% over the past month, but the near-term direction of travel is toward modest covering rather than fresh building. The borrow market reinforces that read: cost to borrow has dropped 15% over the week to 0.44%, its lowest level since early October, and has come down 25% over the past month. Availability is loose at 436% of outstanding short interest, well above the 52-week trough of 298%, meaning there is no pressure on existing shorts from the lending pool. The options market has shifted noticeably. The put/call ratio dropped from above 2.2 for most of the past month to 1.37 this week, the lowest reading in that stretch, though it remains above the long-run average given the noisy 20-day mean of 3.4 (inflated by a September spike to 25). The recent step-down points to less put-heavy positioning, consistent with some defensive trades being unwound.
The analyst community tells a grimmer story. The direction of target cuts has been one-way since the August earnings miss. Oppenheimer's Bryan Blair, who maintained an Outperform rating, cut his target this week from $135 to $110. JP Morgan had already moved from $125 to $95 in early October while holding Overweight. Roth Capital and Stifel had trimmed in July and September respectively. The mean consensus target now sits at roughly $120, against a current price of $65.19, implying a wide apparent gap, but the targets have been moving fast and should be read with that trajectory in mind rather than as a stable reference point. The bull case rests on the Eddyfi acquisition reshaping the margin profile: roughly 65% adjusted gross margin and 55% recurring revenue in that segment, combined with a commercial funnel of around $450 million in cross-selling opportunity across welding, inspection and monitoring. The bear case is simpler: Q2 core adjusted EPS of $1.35 missed consensus, FY26 guidance of $5.40 to $5.50 came in below the prior $5.69 consensus, and net debt of $2.32 billion at 3.7x adjusted EBITDA leaves limited room for error. The EV/EBITDA multiple runs at 7.5x, the P/E at 10.5x, both modest for an industrial, but EPS momentum scores rank in the bottom quarter of the universe, 23rd percentile on a 30-day basis and 22nd on 90-day.
The ownership register carries one detail worth noting. Mitchell P. Rales, ESAB's Executive Chair, filed a Schedule 13D/A in June disclosing a stake that had grown from 5.9% to 7.1% of shares outstanding. A 13D filing signals activist or at minimum highly engaged intent, distinct from the passive 13G filings lodged by index managers. T. Rowe Price, the largest institutional holder with roughly 19% of shares, has also been adding, though its two entities have been moving in opposite directions in recent filings. As with all 13D/G disclosures, stakes are as last reported around the 5% threshold and a holder can fall below that level without a subsequent filing.
Earnings history is limited but pointed. The August 2026 print produced a one-day move of roughly minus 0.7%, but the five-day reaction was minus 7.9%, suggesting the market took time to fully digest the guidance cut. The prior print in May produced a one-day gain of 9.5% before giving back about 1% over the following week. The stock is down 2.5% over the past week, against a median gain of roughly 0.9% for its closest peers. IR and LECO were each off less than 1% on the week, while SWK added 3.7%. Wikipedia attention for ESAB ran 1.7 standard deviations above its own 90-day average in late September, a signal of elevated retail interest at a point when the stock was trading near multi-year lows.
With nine days to the October 30 print, the key data to watch is whether analyst targets stabilise or continue their downward march, and whether the one-day versus five-day divergence in past earnings reactions repeats.
Stocks in this article
See the live data behind this article on ORTEX.
Open ESAB on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 20:54
- Data as of
- 21 Oct 2026, 20:51
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.